The Infectious Diseases Society of America has announced Dr. Paul E. Sax as the new editor-in-chief of Clinical Infectious Diseases. Dr. Sax, who currently serves as editor-in-chief of CID’s sister journal, Open Forum Infectious Diseases, will succeed Dr. Robert T. Schooley on July 1, 2022, following Dr. Schooley’s years of distinguished service to the journal and the Society.
Dr. Sax is clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard Medical School. At the Brigham, he holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases. For the last 20 years, he has been the associate program director for the Mass General Brigham combined ID fellowship, a role he will be giving up to take on the CID editor position.
An internationally recognized clinician and clinical teacher in infectious diseases, in particular HIV, Dr. Sax also has been actively involved in research. Ongoing areas of investigation include clinical trials of antiretroviral therapies, cost-effectiveness of strategies for HIV management, and toxicity of antiretroviral therapy. Like all ID specialists, for the last two years, he has been closely involved in the clinical management and prevention of COVID-19, including frequent communications with the medical and lay public about the disease.
Dr. Sax is the founding editor of IDSA’s open access journal, Open Forum Infectious Diseases, which was launched in 2014. Under his editorship, OFID’s impact factor has risen to 3.835, and the journal has developed a significant online presence. Alongside its published content, OFID hosts a free podcast featuring interviews with infectious disease experts and other people. Dr. Sax has also fostered a close relationship between OFID and CID, which he hopes will continue in his new role.
As Dr. Sax will be stepping down as editor-in-chief of Open Forum Infectious Diseases, IDSA will be launching an open search for OFID’s next editor-in-chief and will be appointing an interim editor to lead the journal until a permanent editor is named.
Prior to his tenure at OFID, Dr. Sax served as editor-in-chief of NEJM Journal Watch HIV/AIDS. He remains a member of the editorial board of NEJM Journal Watch Infectious Diseases and writes their HIV and ID Observations blog. He also serves as the HIV section editor for UpToDate.
Click here to read the original press release.
